ABOUT ABBV-744 IN CLINICAL TRIALS FOR NON-SMALL CELL LUNG CANCER (NSCLC)

Further studies in progress propose that ARV-825 might also be effective in maximizing the reaction to estrogen deprivation (aromatase inhibition), another element of standard of treatment in ER+ breast cancer.- "Our study uncovered the vital part in the KLF16/MYC regulatory axis in modulating tumor progress and chemotherapy sensitivity in BLCA, su